Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $771,902 (100.0% shares, 0.0% debt)

Holdings (17)

APGE APOGEE THERAPEUTICS INC 11.5%

Value ($000) $88,973 Shares 2,048,647 Est. Cost $22.03 Unrealized +72.7%

AXSM AXSOME THERAPEUTICS INC 11.0%

Value ($000) $85,096 Shares 815,176 Est. Cost $49.79 Unrealized +112.7%

ELVN ENLIVEN THERAPEUTICS INC 9.6%

Value ($000) $74,452 Shares 3,711,444 Est. Cost $18.70 Unrealized +1.3%

SRRK SCHOLAR ROCK HLDG CORP 8.4%

Value ($000) $64,607 Shares 1,824,031 Est. Cost $32.27 Unrealized -2.7%

SYRE SPYRE THERAPEUTICS INC 7.8%

Value ($000) $60,151 Shares 4,018,101 Est. Cost $31.80 Unrealized -53.5%

NUVL NUVALENT INC 7.2%

Value ($000) $55,513 Shares 727,563 Est. Cost $22.67 Unrealized +222.8%

DNTH DIANTHUS THERAPEUTICS INC 6.5%

Value ($000) $50,435 Shares 2,707,191 Est. Cost $15.37 Unrealized +22.1%

KNSA KINIKSA PHARMACEUTICALS INTL 6.4%

Value ($000) $49,054 Shares 1,772,839 Est. Cost $21.28 Unrealized +19.6%

VRDN VIRIDIAN THERAPEUTICS INC 6.3%

Value ($000) $48,370 Shares 3,459,913 Est. Cost $16.55 Unrealized -18.0%

COGT COGENT BIOSCIENCES INC 5.8%

Value ($000) $44,700 Shares 6,225,641 Est. Cost $8.53 Unrealized -35.0%

ORKA ORUKA THERAPEUTICS INC 4.9%

Value ($000) $37,799 Shares 3,371,922 Est. Cost $34.30 Unrealized -69.6%

JBIO JADE BIOSCIENCES INC 4.2%

Value ($000) $32,171 Shares 3,220,368 Est. Cost $33.31 Unrealized 0.0%

CBIO CRESCENT BIOPHARMA INC. 2.9%

Value ($000) $22,400 Shares 1,387,866 Est. Cost $21.15 Unrealized 0.0%

— ASTRIA THERAPEUTICS INC 2.5%

Value ($000) $19,050 Shares 3,554,129 Est. Cost $9.99 Unrealized —

ZBIO ZENAS BIOPHARMA INC 2.4%

Value ($000) $18,341 Shares 1,892,806 Est. Cost $17.98 Unrealized -45.8%

IKT INHIBIKASE THERAPEUTICS INC 1.5%

Value ($000) $11,944 Shares 6,125,000 Est. Cost $2.49 Unrealized -21.5%

CTMX CYTOMX THERAPEUTICS INC 1.1%

Value ($000) $8,845 Shares 3,896,582 Est. Cost $1.61 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
APGE	APOGEE THERAPEUTICS INC	2,048,647	$88,973	11.5%	$22.03	+72.7%	COM	03770N101
AXSM	AXSOME THERAPEUTICS INC	815,176	$85,096	11.0%	$49.79	+112.7%	COM	05464T104
ELVN	ENLIVEN THERAPEUTICS INC	3,711,444	$74,452	9.6%	$18.70	+1.3%	COM	29337E102
SRRK	SCHOLAR ROCK HLDG CORP	1,824,031	$64,607	8.4%	$32.27	-2.7%	COM	80706P103
SYRE	SPYRE THERAPEUTICS INC	4,018,101	$60,151	7.8%	$31.80	-53.5%	COM NEW	00773J202
NUVL	NUVALENT INC	727,563	$55,513	7.2%	$22.67	+222.8%	COM	670703107
DNTH	DIANTHUS THERAPEUTICS INC	2,707,191	$50,435	6.5%	$15.37	+22.1%	COM	252828108
KNSA	KINIKSA PHARMACEUTICALS INTL	1,772,839	$49,054	6.4%	$21.28	+19.6%	ORD SHS CL A	G52694109
VRDN	VIRIDIAN THERAPEUTICS INC	3,459,913	$48,370	6.3%	$16.55	-18.0%	COM	92790C104
COGT	COGENT BIOSCIENCES INC	6,225,641	$44,700	5.8%	$8.53	-35.0%	COM	19240Q201
ORKA	ORUKA THERAPEUTICS INC	3,371,922	$37,799	4.9%	$34.30	-69.6%	COM	687604108
JBIO	JADE BIOSCIENCES INC	3,220,368	$32,171	4.2%	$33.31	0.0%	COM NEW	008064206
CBIO	CRESCENT BIOPHARMA INC.	1,387,866	$22,400	2.9%	$21.15	0.0%	COM	G2545C104
—	ASTRIA THERAPEUTICS INC	3,554,129	$19,050	2.5%	$9.99	—	COM	04635X102
ZBIO	ZENAS BIOPHARMA INC	1,892,806	$18,341	2.4%	$17.98	-45.8%	COM	98937L105
IKT	INHIBIKASE THERAPEUTICS INC	6,125,000	$11,944	1.5%	$2.49	-21.5%	COM NEW	45719W205
CTMX	CYTOMX THERAPEUTICS INC	3,896,582	$8,845	1.1%	$1.61	0.0%	COM	23284F105